Your browser is no longer supported. Please, upgrade your browser.
Settings
GKOS Glaukos Corporation daily Stock Chart
GKOS [NYSE]
Glaukos Corporation
Index- P/E- EPS (ttm)-0.03 Insider Own0.30% Shs Outstand33.99M Perf Week-0.23%
Market Cap880.34M Forward P/E231.25 EPS next Y0.11 Insider Trans-94.86% Shs Float33.07M Perf Month-9.60%
Income-1.00M PEG- EPS next Q0.01 Inst Own- Short Float14.89% Perf Quarter-17.52%
Sales150.80M P/S5.84 EPS this Y105.80% Inst Trans6.73% Short Ratio6.40 Perf Half Y-36.13%
Book/sh3.83 P/B6.76 EPS next Y650.00% ROA-0.70% Target Price43.88 Perf Year-23.40%
Cash/sh3.20 P/C8.09 EPS next 5Y40.00% ROE-0.80% 52W Range23.08 - 52.49 Perf YTD-24.49%
Dividend- P/FCF71.00 EPS past 5Y- ROI3.60% 52W High-48.90% Beta-
Dividend %- Quick Ratio6.50 Sales past 5Y- Gross Margin85.90% 52W Low16.23% ATR1.59
Employees264 Current Ratio6.90 Sales Q/Q36.50% Oper. Margin-1.50% RSI (14)47.23 Volatility6.34% 5.60%
OptionableYes Debt/Eq0.00 EPS Q/Q12.40% Profit Margin-0.60% Rel Volume0.57 Prev Close25.90
ShortableYes LT Debt/Eq0.00 EarningsNov 07 AMC Payout- Avg Volume768.80K Price26.82
Recom1.50 SMA202.77% SMA50-11.22% SMA200-30.46% Volume196,130 Change3.55%
Mar-02-17Reiterated Cantor Fitzgerald Overweight $45 → $54
Jan-06-17Upgrade Stifel Hold → Buy $42 → $45
Oct-27-16Initiated Wells Fargo Outperform
Aug-02-16Reiterated Cantor Fitzgerald Buy $35 → $41
Jun-03-16Initiated Cantor Fitzgerald Buy $35
Apr-08-16Initiated Stifel Hold
Feb-09-16Initiated Piper Jaffray Overweight $19
Jul-20-15Initiated JP Morgan Overweight $38
Jul-20-15Initiated Goldman Neutral $29
Jul-20-15Initiated Cantor Fitzgerald Buy $35
Jul-20-15Initiated BofA/Merrill Buy
Dec-11-17 04:30PM  Why SCANA, Glaukos, and Juno Therapeutics Slumped Today Motley Fool
08:03AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Dec-01-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-30-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
07:00AM  Glaukos Announces Issuance of New U.S. Patent Business Wire
Nov-29-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-27-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
07:30AM  Research Report Identifies Walker & Dunlop, Vanda Pharmaceuticals, Acushnet, SS&C Technologies, ManpowerGroup, and Glaukos with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-22-17 08:07AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-17-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-16-17 11:38AM  ETFs with exposure to Glaukos Corp. : November 16, 2017 Capital Cube
08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-15-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-10-17 12:46PM  Edited Transcript of GKOS earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
08:11AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-07-17 07:03PM  Glaukos beats Street 3Q forecasts Associated Press -10.94%
04:15PM  Glaukos Corporation Announces Third Quarter 2017 Financial Results Business Wire
03:37PM  Is This Why Glaukos Corp. Is Tumbling Today? Motley Fool
10:00AM  Glaukos Corp to Host Earnings Call ACCESSWIRE
Oct-31-17 12:10PM  Glaukos Corp. Value Analysis (NYSE:GKOS) : October 31, 2017 Capital Cube
11:39AM  ETFs with exposure to Glaukos Corp. : October 31, 2017 Capital Cube
07:00AM  Glaukos Announces Participation in Stifel 2017 Healthcare Conference Business Wire
Oct-30-17 08:11AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : October 30, 2017 Capital Cube
Oct-24-17 07:00AM  Glaukos Corporation to Release Third Quarter 2017 Financial Results after Market Close on November 7 Business Wire
Oct-16-17 09:53AM  ETFs with exposure to Glaukos Corp. : October 16, 2017 Capital Cube
Oct-10-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Oct-09-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Oct-06-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Oct-05-17 04:45PM  Glaukos iStent® Products to be Showcased at 2017 European Society of Cataract and Refractive Surgery Business Wire
03:13PM  Why Glaukos Corp. Stock Sank 12.8% in September Motley Fool
08:46AM  Weakness Seen in Glaukos (GKOS) Estimates: Should You Stay Away? Zacks
Oct-03-17 05:06PM  Should You Be Holding Glaukos Corporation (GKOS) Right Now? Simply Wall St.
Oct-02-17 10:51AM  ETFs with exposure to Glaukos Corp. : October 2, 2017 Capital Cube
Sep-29-17 09:00AM  Glaukos Corp. :GKOS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-15-17 09:46AM  Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : September 15, 2017 Capital Cube -7.21%
Sep-14-17 12:07PM  Here's Why Glaukos Corp. Stock Is Stumbling Today Motley Fool -18.12%
10:31AM  Is It Too Late To Buy Glaukos Corporation (GKOS)? Simply Wall St.
06:00AM  Glaukos to Outline Growth Strategy at Investor Day Business Wire
Sep-12-17 08:02AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Sep-11-17 10:07AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Sep-08-17 03:00AM  IBD Rating Upgrades: Glaukos Flashes Improved Price Strength Investor's Business Daily
Sep-07-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Sep-04-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-31-17 07:00AM  Glaukos Announces 2017 Investor Day and Webcast Business Wire
Aug-30-17 04:06PM  Edited Transcript of GKOS earnings conference call or presentation 2-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-24-17 07:00AM  Glaukos Announces Participation in Wells Fargo Healthcare Conference Business Wire
Aug-22-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-21-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-17-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-16-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-12-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-11-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-10-17 08:05AM  IHS Markit Score downgrades Glaukos Corp to 17 out of 100, ranking negatively in one out of three available IHS Markit categories. Markit
Aug-04-17 03:17AM  Glaukos reports 2Q loss Associated Press
Aug-03-17 01:17PM  Here's What's Pressuring Glaukos Corp Stock Today Motley Fool -7.48%
Aug-02-17 04:10PM  Glaukos Corporation Announces Second Quarter 2017 Financial Results Business Wire
Aug-01-17 06:27PM  Glaukos Corp. Value Analysis (NYSE:GKOS) : August 1, 2017 Capital Cube
09:20AM  Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : August 1, 2017 Capital Cube
Jul-24-17 04:08PM  ETFs with exposure to Glaukos Corp. : July 24, 2017 Capital Cube
Jul-19-17 08:24AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : July 19, 2017 Capital Cube
Jul-11-17 02:34PM  ETFs with exposure to Glaukos Corp. : July 11, 2017 Capital Cube
Jul-06-17 08:20AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : July 6, 2017 Capital Cube
Jun-30-17 02:57PM  ETFs with exposure to Glaukos Corp. : June 30, 2017 Capital Cube
Jun-22-17 08:12AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : June 22, 2017 Capital Cube
Jun-21-17 07:00AM  Combining Implantation of Glaukos iStent inject® Trabecular Micro-Bypass with Topical Travoprost Provides Sustained IOP Reduction and Favorable Safety Profile, According to New Study Business Wire
Jun-19-17 03:24PM  ETFs with exposure to Glaukos Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:50AM  Glaukos Corp. :GKOS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-10-17 02:06PM  3 Growth Stocks for Bold Investors Motley Fool
May-30-17 04:30PM  Glaukos Announces Participation in William Blair Growth Stock Conference Business Wire
May-24-17 12:05PM  Which Stocks Are Showing Rising Relative Strength? Investor's Business Daily
12:03PM  Can This 2015 Medical IPO Inject New Life Into Its Stock? Investor's Business Daily
May-22-17 04:30PM  Study Reveals Potential Cost Efficiency of Using Two Glaukos iStent® Trabecular Micro-Bypass Stents to Treat Elevated IOP in Glaucoma Patients Business Wire
May-06-17 07:50PM  Edited Transcript of GKOS earnings conference call or presentation 3-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-03-17 07:27PM  Glaukos beats Street 1Q forecasts Associated Press
04:15PM  Glaukos Corporation Announces First Quarter 2017 Financial Results Business Wire
07:00AM  Glaukos Completes Patient Enrollment in Phase II Clinical Trial for iDose Travoprost Intraocular Implant in Glaucoma Patients Business Wire
May-02-17 07:00AM  Glaukos Announces Participation in Bank of America Merrill Lynch 2017 Health Care Conference Business Wire
May-01-17 04:59PM  Glaukos Corp. Value Analysis (NYSE:GKOS) : May 1, 2017 Capital Cube
07:00AM  Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery Business Wire
Apr-28-17 08:19AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : April 28, 2017 Capital Cube
06:54AM  Cerner (CERN) Earnings and Revenues Beat Estimates in Q1 Zacks
Apr-27-17 09:46AM  CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y Zacks
Apr-26-17 10:32AM  Stryker (SYK) Earnings and Revenues Beat Estimates in Q1 Zacks
Apr-19-17 07:00AM  Glaukos Corporation to Release First Quarter 2017 Financial Results after Market Close on May 3 Business Wire
Apr-14-17 08:24AM  Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : April 14, 2017 Capital Cube
Apr-13-17 05:02PM  Why Apogee Enterprises, Embraer, and Glaukos Slumped Today Motley Fool -7.60%
04:42PM  Glaukos Dives To 1-Month Low On Proposal To Slash Reimbursements Investor's Business Daily
07:00AM  International Study Shows Two Glaukos iStent® Trabecular Micro-Bypass Stents and One Topical Medication Deliver Sustained IOP Reduction Business Wire
Apr-12-17 04:30PM  Glaukos Corporation Acquires IOP Sensor System from DOSE Medical Business Wire
Apr-10-17 10:20AM  3 Stocks That Are Overvalued Motley Fool -7.61%
Apr-09-17 03:26PM  Glaukos shares risk steep decline as rivals pressure - Barron's Reuters
03:11PM  Glaukos shares risk steep decline as rivals pressure - Barron's Reuters
Apr-08-17 12:21AM  [$$] Skeptics Eye Potential Trouble for Glaukos Barrons.com
Apr-05-17 04:49PM  ETFs with exposure to Glaukos Corp. : April 5, 2017 Capital Cube
Mar-21-17 01:04PM  GLAUKOS CORP Financials
Mar-16-17 07:00AM  Glaukos Announces Five-Year Extensions for Three Category III CPT Codes Related to Micro-Invasive Glaucoma Surgery Business Wire
Mar-15-17 04:11PM  GLAUKOS CORP Files SEC form 10-K, Annual Report
Mar-10-17 04:32PM  GLAUKOS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-06-17 01:42PM  ETFs with exposure to Glaukos Corp. : March 6, 2017 Capital Cube
Mar-03-17 11:21AM  Glaukos Corp. :GKOS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Capital Cube -6.27%
Glaukos Corporation, an ophthalmic medical technology company, focuses on the development and commercialization of products and procedures designed to treat glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry with the goal of achieving intraocular pressure reduction; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration. It markets its products through direct sales force in the United States and internationally, as well as through distribution partners in Europe, the Asia Pacific, and internationally. Glaukos Corporation was founded in 1998 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gilliam Joseph ECFO, SVP Corporate DevelopmentNov 22Buy23.842,10050,064102,100Nov 27 01:03 PM
Burns Thomas WilliamChief Executive OfficerSep 07Option Exercise1.7073,788125,167284,028Sep 08 05:39 PM
Burns Thomas WilliamChief Executive OfficerSep 07Sale41.3673,7883,051,872210,240Sep 08 05:39 PM
Burns Thomas WilliamChief Executive OfficerSep 05Option Exercise1.931,2122,333211,452Sep 06 08:17 PM
Burns Thomas WilliamChief Executive OfficerSep 05Sale41.251,21249,995210,240Sep 06 08:17 PM
ORBIMED ADVISORS LLCDirectorSep 05Sale39.09425,20016,621,7307,895Sep 05 09:27 PM
SILVERSTEIN JONATHANDirectorSep 05Sale39.09425,20016,621,7307,895Sep 05 09:21 PM
SILVERSTEIN JONATHANDirectorSep 01Sale37.72110,0784,152,14211,907Sep 05 09:21 PM
ORBIMED ADVISORS LLCDirectorSep 01Sale37.72110,0784,152,14211,907Sep 05 09:27 PM
ORBIMED ADVISORS LLCDirectorAug 31Sale37.8244,9221,698,95012,945Sep 05 09:27 PM
SILVERSTEIN JONATHANDirectorAug 31Sale37.8244,9221,698,95012,945Sep 05 09:21 PM
SILVERSTEIN JONATHANDirectorAug 17Sale37.85226,9208,588,92213,369Aug 17 05:27 PM
ORBIMED ADVISORS LLCDirectorAug 17Sale37.85226,9208,588,92213,369Aug 17 05:20 PM
ORBIMED ADVISORS LLCDirectorAug 16Sale38.0165,5802,492,69615,509Aug 17 05:20 PM
SILVERSTEIN JONATHANDirectorAug 16Sale38.0165,5802,492,69615,509Aug 17 05:27 PM
SILVERSTEIN JONATHANDirectorAug 15Sale38.2932,5001,244,42516,128Aug 17 05:27 PM
ORBIMED ADVISORS LLCDirectorAug 15Sale38.2932,5001,244,42516,128Aug 17 05:20 PM
SILVERSTEIN JONATHANDirectorMar 14Sale44.5474,1003,300,41416,435Mar 14 07:47 PM
ORBIMED ADVISORS LLCDirectorMar 14Sale44.5474,1003,300,41416,435Mar 14 07:39 PM
ORBIMED ADVISORS LLCDirectorMar 13Sale45.30211,4109,577,45417,134Mar 14 07:39 PM
SILVERSTEIN JONATHANDirectorMar 13Sale45.30211,4109,577,45417,134Mar 14 07:47 PM
SILVERSTEIN JONATHANDirectorMar 10Sale45.9897,0284,461,34719,129Mar 14 07:47 PM
ORBIMED ADVISORS LLCDirectorMar 10Sale45.9897,0284,461,34719,129Mar 14 07:39 PM
SILVERSTEIN JONATHANDirectorMar 03Sale47.0555,7722,624,07320,044Mar 07 06:52 PM
ORBIMED ADVISORS LLCDirectorMar 03Sale47.0555,7722,624,07320,044Mar 07 06:48 PM
Burns Thomas WilliamChief Executive OfficerFeb 02Sale42.5850,0002,129,000210,240Feb 03 04:11 PM
Calcaterra Chris M.Chief Commercial OfficerJan 13Option Exercise7.283,72327,085243,723Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 13Option Exercise7.286,31345,9277,701Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 13Sale40.033,723149,032240,000Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 13Sale40.016,313252,5831,388Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 12Option Exercise7.2814,321104,18515,709Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 12Option Exercise7.2814,413104,855254,413Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 12Sale40.0014,321572,8401,388Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 12Sale40.0014,413576,520240,000Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 09Option Exercise7.2820,000145,500260,000Jan 11 04:30 PM
Calcaterra Chris M.Chief Commercial OfficerJan 09Sale38.0220,000760,400240,000Jan 11 04:30 PM
HARRISON RICHARD LCFO & TreasurerJan 06Option Exercise4.6320,63495,60322,022Jan 09 04:00 PM
HARRISON RICHARD LCFO & TreasurerJan 06Sale35.5820,634734,1421,388Jan 09 04:00 PM